MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Changes in word fluency tasks and cognitive function before and after the COVID-19 epidemic in patients with Parkinson’s disease:PD.

    M. Sagawa, K. Hasegawa, A. Kumon, M. Saruwatari (Kanagawa, Japan)

    Objective: The purpose of this study is to investigate the changes in cognitive function and frontal lobe function in PD before and after self-restraint due…
  • 2023 International Congress

    Neurophysiological markers of motor reserve in Parkinson’s disease

    M. Passaretti, S. Rinaldo, E. Orunesu, D. Rossi Sebastiano, G. de Vigili, G. Barbiera, A. Braccia, G. Paparella, M. de Riggi, P. Lanteri, A. Berardelli, A P. Strafella, M. Bologna, R. Eleopra, R. Cilia (Rome, Italy)

    Objective: Our objective was to investigate Motor Reserve (MR) in idiopathic Parkinson’s Disease (PD). Background: MR is defined as the resilience mechanisms of the brain…
  • 2023 International Congress

    Impact of the severity of Parkinson’s disease on skin elasticity

    SY. You, HJ. Park (Daegu, Republic of Korea)

    Objective: To investigate changes in skin elasticity according to the severity of symptoms of Parkinson's disease. Background: Parkinson's disease (PD) is a neurodegenerative disease caused…
  • 2023 International Congress

    Touchscreen nQ application as a remote digital biomarker in Parkinson disease

    J. Yu, P. Gandara, O. Phillips, J. Liao, A. Holmes, I. Mondesire-Crump, J. Syrotenko, S. Mruthik, T. Arroyo-Gallego, H. Fernandez (Cleveland, USA)

    Objective: To characterize the viability of nQ machine learning platform via touchscreen keyboard as a digital biomarker for Parkinson disease Background: To date, a reliable…
  • 2023 International Congress

    Serum Metabolomics in Parkinson’s Disease: Correlations with Fecal Microbiome, Fecal Metabolomics and Clinical Status

    TS. Toh, CW. Chong, MF. Loke, JW. Hor, LC. Lit, J. Bowman, SL. Song, CSJ. Teh, S-Y. Lim, AH. Tan (Kuala Lumpur, Malaysia)

    Objective: To investigate the correlations between serum metabolites with fecal microbiome, fecal metabolites, and clinical phenotypes in patients with Parkinson’s disease (PD). Background: There is…
  • 2023 International Congress

    An international consensus statement for rehabilitation care in Parkinson’s disease

    J. Goldman, D. Volpe, T. Ellis, M. Hirsch, J. Johnson, J. Wood, A. Aragon, R. Biundo, A. Dirocco, G. Kasman, R. Iansek, J. Miyasaki, V. Mcconvey, M. Munneke, S. Pinto, K. St Clair, S. Toledo, M. York, R. Todaro, N. Yarab, K. Wallock (Chicago, USA)

    Objective: To develop a consensus statement regarding the incorporation of rehabilitation in Parkinson’s (PD) care. Background: As a complex, progressive disorder, PD can impact daily…
  • 2023 International Congress

    Neuropsychiatric Symptoms in Early-Onset Parkinson’s Disease

    C. Piat, E. Camerucci, A. Mullan, K. Ghoniem, J. Jacobson, G. Patanè, P. Turcano, R. Savica (Rochester, USA)

    Objective: To describe the neuropsychiatric symptoms of Early-Onset Parkinson’s Disease (EOPD) patients in an incident cohort study from 1991 to 2010 in Olmsted County, Minnesota…
  • 2023 International Congress

    Effects on voice sound level and brain connectivity after HiCommunication: a novel speech and communication treatment for Parkinson’s disease

    H. Steurer, F. Albrecht, A. Razi, J. Körner Gustafsson, E. Franzén, E. Schalling (Stockholm, Sweden)

    Objective: This study aimed to evaluate the clinical relevance of effects on voice sound level (Lv) as well as brain connectivity using resting-state functional MRI…
  • 2023 International Congress

    Chronotropic incompetence – a possible marker of severe Parkinson’s disease phenotype?

    M. Andréasson, P. Svenningsson (Stockholm, Sweden)

    Objective: Perform a retrospective analysis of patients with Parkinson’s disease (PD) who previously have undergone a cardiac stress test, with the aim of comparing clinical…
  • 2023 International Congress

    A Systematic Review of the Type, Timing, Frequency and Durability of Effect in Parkinson’s Disease Physical Therapy

    M. El Hayek, J. Jofili Lopes, J. Lelaurin, A. Abi Nehme, K. Au, M. Okun, R. Salloum (Gainesville, USA)

    Objective: To evaluate all current evidence on the types, timing, frequency, duration, and outcomes of physical therapy (PT) regimens applied in Parkinson’s disease (PD). Background:…
  • « Previous Page
  • 1
  • …
  • 112
  • 113
  • 114
  • 115
  • 116
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley